ABSTRACT Background: The relative potency of 25-hydroxyvitamin D 3 to vitamin D 3 needs to be better defined so that food-composition tables can better reflect the true vitamin D nutritive value of certain foods.
INTRODUCTION
For individuals aged !1 y, an Estimated Average Requirement and Recommended Dietary Allowance of 400 and 600 IU vitamin D/d (800 IU vitamin D/d for individuals .70 y of age), respectively, has been established in North America (1) . The mean daily intake (MDI) 5 in the range of 40-428 IU vitamin D/d has been reported for children, teenagers, and adults in North America (1, 2) and Europe (3) . Clearly, there is a need for sustainable food-based strategies to bridge the gap between current and recommended intakes of vitamin D to minimize the prevalence of vitamin D deficiency, but the development of such strategies requires, in the first instance, the ability to accurately assess vitamin D intakes in the population, including the main food contributors to the MDI of vitamin D.
In countries where the fortification of food with vitamin D is not common, it has been suggested that meat could be a significant source of vitamin D (4) . Data on vitamin D intakes from 2 successive national nutrition surveys in Ireland over the past 14 y suggested that 30%, 12-14%, and 9% of the MDI of vitamin D in 18-64-y-olds comes from meat and meat products, fish and fish products, and egg and egg-dish food groupings, respectively (4, 5) . Likewise, these 3 food groupings collectively make a significant contribution (55.5%) to the MDI of vitamin D in adults in the United Kingdom (6) . Even in countries where fortification with vitamin D is common, the consumption of meat and related products may be important in certain ethnic groups. For example, Van Horn et al (7) recently showed that, in US adolescent girls in the National Heart, Lung and Blood Institute Growth and Health Study, the meat and bean food group contributed ;4% and 26% to the MDI of vitamin D in white and African American girls, respectively. Some of the contributions of these food groups to vitamin D nutriture are due to the fact that 25-hydroxyvitamin D 3 , which is one of the major metabolites of vitamin D, is present in meat, fish, and eggs (8) (9) (10) (11) . Moreover, it is assumed in the United Kingdom (and Danish and Swiss) food-composition databases that the 25-hydroxyvitamin D 3 present in these foods has 5 times the activity of vitamin D 3 (12) (13) (14) , which is accounted for when their total vitamin D content is estimated. However, Ovesen et al (15) pointed out that there is, as yet, no consensus on the conversion factor that should be used for 25-hydroxyvitamin D 3 to calculate vitamin D activity, and estimates of the factor that arose from studies in vitamin D-deficient rats, which were performed .35-45 y ago, varied from 1.5 to 5 (16) (17) (18) (19) . More recently, Jakobsen et al (20) showed that plasma 25-hydroxyvitamin D [25(OH)D] concentrations were similar in pigs fed an equal amount of vitamin D 3 and the metabolite for 11 wk.
Priority needs to be given to data from human studies that have experimentally examined the relative potency of 25-hydroxyvitamin D 3 to vitamin D; however, such data have been scant. Conversion-factor estimates of ;1.4 and 10 arose from 2 intervention studies in patients who required vitamin D treatment (21, 22) ; however, caution is needed because both studies had design characteristics that may have affected these estimates. In contrast, Bischoff-Ferrari et al (23) very recently showed that healthy postmenopausal women (n = 10 women per group) who were supplemented with 20 lg 25-hydroxyvitamin D 3 /d had an ;3-fold greater increase in plasma 25(OH)D after 16 wk than did women supplemented with 20 lg vitamin D 3 /d. Clearly, additional research is needed to better define the conversion factor so that food-composition tables can better reflect the true vitamin D nutritive value of meats, fish, and eggs.
The aim of this study was to perform a randomized, controlled intervention study in apparently healthy, free-living adults (aged !50 y) to investigate whether the intake of 25-hydroxyvitamin D 3 is 5 times more potent in raising serum 25(OH)D concentrations during winter than an equivalent amount of vitamin D 3 .
SUBJECTS AND METHODS

Subjects
A total of 58 apparently healthy, free-living adults aged !50 y were recruited in this 10-wk vitamin D 3 and 25-hydroxyvitamin D 3 intervention trial (www.clinicaltrials.gov; NCT01398202). Subjects were recruited in the Cork area through the use of advertisements placed around University College Cork as well as across the location. Because we predicted that it would be more difficult to recruit men than women, we aimed to recruit a ratio of ;55:45 women to men. White men and women aged !50 y who provided consent were included in the study. Volunteers were excluded if they were unwilling to discontinue the consumption of vitamin D-containing supplements 8 wk before the initiation of the study and throughout the study. Volunteers were also excluded if they planned to take a winter vacation (during the course of the 10-wk intervention) to a location at which either the altitude or the latitude was predicted to result in significant cutaneous vitamin D synthesis from solar radiation (eg, a winter sun coastal resort or a mountain ski resort) or if they used tanning facilities of any type. A severe medical illness, hypercalcemia, known intestinal malabsorption syndrome, excessive alcohol use, and use of medications known to interfere with vitamin D metabolism were also reasons for exclusion. The study was approved by the Clinical Research Ethics Committee of the Cork Teaching Hospitals, University College Cork. All participants gave their written consent in accordance with the Helsinki declaration.
Design and conduct of study
This was a double-blind, placebo-controlled trial in which older adults were randomly assigned to receive a capsule that contained a placebo, 20 lg vitamin D 3 , or 7 or 20 lg 25-hydroxyvitamin D 3 daily for 10 wk. Data from Rossini et al (22) and Jetter et al (24) , which was a preliminary publication of the Bischoff-Ferrari et al (23) study, that were available at the time the current study was being planned suggested that the relative potency of 25-hydroxyvitamin D 3 and vitamin D 3 in raising serum 25(OH)D was ;1 and ;3, respectively. Therefore, the doses of 20 and 7 lg 25-hydroxyvitamin D 3 and 20 lg vitamin D 3 were included in the current study to test the possibility of a conversion factor of 1 and 3, respectively. Random assignment of subjects was centralized and computer generated and accounted for sex. The manufactured crystalline 25-hydroxyvitamin D 3 and vitamin D 3 , both of which were identical spraydried powders stabilized with DL-a-tocopherol, were supplied by DSM Nutritional Products Ltd, and vitamin D 3 and 25-hydroxyvitamin D 3 capsules and matching placebo capsules were produced by Fisher Clinical Services GmbH. The placebo capsules and active (20 lg vitamin D 3 and 7 or 20 lg 25-hydroxyvitamin D 3 ) capsules were identical in appearance and taste. The vitamin D 3 or 25-hydroxyvitamin D 3 content of the capsules was confirmed by in-house laboratory analysis within DSM Nutritional Products Ltd. Compliance was assessed by capsule counting. An a priori decision was made to include only those subjects who exceeded 80% compliance. The allocation remained concealed until the final analyses, and all outcomes were reported by people who were masked to the allocation scheme.
The study was carried out in Cork, Republic of Ireland (latitude 51°N). All subjects were recruited and commenced the intervention study between 17 and 28 January 2011 and finished 10 wk later between 21 March and 8 April 2011, during which period of time vitamin D status would be expected to decline to a nadir (25) . During the intervention phase, each participant was met by researchers on 3 occasions at the study center, once each at the baseline (week 0), midpoint (week 5), and endpoint (week 10) of the study. At each visit, an overnight fasting blood sample was taken from each participant between 0830 and 1030 by a trained phlebotomist. Blood was collected by venepuncture into an evacuated tube with no additive and processed to serum, which was immediately stored at 280°C until required for analysis. Anthropometric measures, including height and weight, were taken as described previously (26) . The habitual intake of calcium and vitamin D was estimated by using a validated food-frequency questionnaire (27, 28) that was administered by a research nutritionist, and a health and lifestyle questionnaire, which assessed physical activity, general health, smoking status, and alcohol consumption, was completed at baseline. Participants were contacted regularly by phone or correspondence to promote compliance and encourage completion of the study protocol.
Laboratory analysis
Serum 25(OH)D
The 25(OH)D concentrations were measured at University College Cork in all serum samples by using an ELISA (OCTEIA 25-Hydroxy Vitamin D; Immuno Diagnostic Systems Ltd). The intraassay and interassay CVs for the ELISA method were 5.9% and 6.6%, respectively. This ELISA assay is used for the quantitative determination of serum and plasma 25(OH)D, additional details of which have been described previously (29) . The quality and accuracy of serum 25(OH)D analysis in our 25 -HYDROXYVITAMIN D 3 COMPARED WITH VITAMIN D 3 laboratory are assured on an ongoing basis by participation in the Vitamin D External Quality Assessment Scheme (Charing Cross Hospital). A comparison of the performance of our ELISA assay with that of our liquid chromatography-mass spectroscopy method in relation to frozen Vitamin D External Quality Assessment Scheme samples from the first 3 quarters of 2011 (n = 15) showed a high correlation (ELISA = 1.0301 · liquid chromatography-mass spectroscopy + 0.1224; r = 0.992) and a very good agreement by using a Bland-Altman difference plot.
Serum intact parathyroid hormone
Serum parathyroid hormone (PTH) concentrations were measured at University College Cork in all serum samples by using an ELISA (intact PTH; MD Biosciences Inc). The intraassay and interassay CVs were 3.4% and 3.8%, respectively.
Serum total calcium
Total calcium and albumin concentrations in all serum samples were measured at Cork University Hospital, Cork, Ireland. Serum calcium concentrations were adjusted for albumin concentrations.
Statistical analysis
As mentioned previously, recent estimates of the conversion factor between vitamin D 3 and 25-hydroxyvitamin D 3 in humans in terms of elevating serum 25(OH)D range from 1.4 to 3.2 (22, 24) . Therefore, we used a 40% increase as the lowest potential increment that we would need to be able to detect between groups treated with 20 lg vitamin D 3 /d and 20 lg 25-hydroxyvitamin D 3 /d. On the basis of the distribution of wintertime serum 25(OH)D data from older adults in our previous study (30) , a study design, whereby 12 volunteers per group were recruited (which included 20% to cover potential dropouts), had 90% power to detect this minimum of a 40% increase in serum 25(OH)D between groups at a = 0.5.
Statistical analysis of the data were conducted with SPSS for Windows (version 16.0; SPSS Inc). Distributions of all variables were tested with Kolmogorov-Smirnov tests. Descriptive statistics (means 6 SDs or medians and IQRs, when appropriate) were determined for all variables. Dietary vitamin D and serum PTH were not normally distributed and, thus, were log transformed to achieve near-normal distributions. Serum concentrations of 25(OH)D, albumin-corrected calcium, age, weight, height, BMI, and dietary calcium were normally distributed. Baseline characteristics of male and female subjects were compared by using unpaired Student's t tests. Baseline characteristics of subjects in the different intervention groups were compared by using the chi-square test (for the ratio of men to women) and 1-factor ANOVA. Linear models of the response in a repeated-measures analysis for differences in serum 25(OH)D, albumin-corrected calcium, and PTH concentrations were constructed. Main effects included dietary treatment and sex. Linear models also included 2-way interactions between main effects. Repeated-measures ANOVA and ANCOVA (with appropriate adjustment for covariates such as age, sex, vitamin D or calcium intake, and baseline amounts of marker being tested) were used to test within and between intervention-group effects of treatment, respectively, on serum 25(OH)D, albumin-corrected calcium, and PTH concentrations, and the Bonferroni-adjusted t test was used for post hoc analysis. P , 0.05 was considered statistically significant.
RESULTS
Baseline characteristics of subjects
Of 58 subjects recruited onto the study, 56 subjects completed the intervention. The progress of these subjects through the trial is shown in Figure 1 . Baseline characteristics of subjects who completed the intervention are shown in Table 1 . Although women were, on average, smaller and lighter than men (both P , 0.0001), there was no difference (P . 0.1) in the mean age, BMI, and serum 25(OH)D, PTH, or albumin-corrected calcium concentrations at baseline or in mean habitual intakes of vitamin D and calcium between men and women (data not shown).
Effects of intervention with vitamin D 3 and 25-hydroxyvitamin D 3
There was no difference (P . 0.8) in the mean age, weight, height, or BMI at baseline in the 4 treatment groups (data not shown). Similarly, there was no significant difference in the proportion of men to women in the mean habitual dietary vitamin D or calcium intake or in mean preintervention serum 25(OH)D, PTH, or albumin-corrected calcium concentrations in treatment groups ( Table 2) .
There were no adverse events reported during the study. Of the 2 dropouts, one subject was from the 20-lg vitamin D 3 /d group and one from the 20-lg 25-hydroxyvitamin D 3 /d group. The dropouts during the intervention phase was for a reason of illness that was unrelated to the intervention or loss of interest, and in no instance was the dropout related to the intervention. One subject failed to exceed our minimum 80% compliance, and this subject was excluded from the main analysis. In the remaining subjects, there was good supplement adherence on the basis of the pill count [the overall median (IQR) compliance was 97.0% (92.0-100%), and compliance was similar in the 4 treatment groups; P = 0.9].
With the use of a compliance-based analysis (with the omission of one subject with compliance below our a priori defined 80%), there was a significant (P 0.0001) time · treatment interaction effect on the mean serum 25(OH)D concentration over the 10-wk intervention period. Within-group repeatedmeasures ANOVA showed that, in all 4 treatment groups, there was a significant change in serum 25(OH)D over time, with the vitamin D 3 and 25-hydroxyvitamin D 3 treatment groups exhibiting variable increases over time and the placebo group exhibiting only minor fluctuations (Table 2 ). Serum 25(OH)D concentrations in the vitamin D 3 group increased significantly (by 29%) by midpoint (week 5) but did not significantly increase any further by week 10 ( Table 2 ). Serum 25(OH)D concentrations in both 25-hydroxyvitamin D 3 groups had increased significantly by week 5 but were further elevated by week 10 ( Table  2) (Table 2) .
There was no significant interaction between treatment and sex (P . There was no significant (P . 0.9) time · treatment interaction effect or treatment effect (P . 0.8) on mean serum albumin-corrected calcium concentrations over the 10-wk intervention period. There was a significant time effect (P , 0.0001) with a minor (2.9%) increase in serum albumin-corrected calcium concentrations at midpoint (week 5) compared with at baseline and that had returned to baseline concentrations again by the endpoint (week 10) ( Table 2 ). None of the subjects exhibited hypercalcemia (serum albumin-corrected calcium concentrations .2.6 nmol/L).
There was a significant (P 0.001) time · treatment interaction effect on the mean serum PTH concentration over the 10-wk intervention period. ANCOVA by intervention groups (adjusted for sex, age, dietary calcium, and baseline PTH in the case of week-5 and -10 analyses) showed that, although there was no significant difference in the mean serum PTH concentration between the 4 groups at baseline, there were significant differences between groups at weeks 5 and 10 ( Table 2) . 
DISCUSSION
Because there is ongoing uncertainty in the data that arose from experimental animal models and very limited human data in relation to the relative effectiveness of dietary 25-hydroxyvitamin D 3 and vitamin D 3 , we compared the effects of daily supplementation with 25-hydroxyvitamin D 3 and vitamin D 3 in raising serum 25(OH)D in late winter after a double-blind, randomized, controlled intervention study over 10 wk in 58 apparently healthy white subjects aged !50 y who were living at 51°N. We showed that, when expressed per microgram of vitamin D compound, daily supplementation with 25-hydroxyvitamin D 3 was between 4.2 and 5 times as effective as vitamin D 3 in raising wintertime serum 25(OH)D in older adults. These data largely support the choice of some food-composition databases (12) (13) (14) to apply a conversion factor of 5 for 25-hydroxyvitamin D 3 in meat and poultry and also may provide the basis for accounting for the contribution of 25-hydroxyvitamin D 3 in the total vitamin D activity of food in those food-composition databases for which future versions will include the content of the metabolite.
Because of variable study-design characteristics, a comparison of the conversion estimates of the current study with those of previous studies needs to be done cautiously. Our conversion estimates in older adult men and women were higher than those reported previously in older women (22, 24) ; however, there was no evidence of a sex effect on the response of serum 25(OH)D concentrations to treatment. In the study by Rossini et al (22) , which was in osteopenic and osteoporotic women who were complicated by hypovitaminosis D, 25-hydroxyvitamin D 3 was administered weekly as drops (with a daily calcium supplementation), and vitamin D 3 in combination with calcium was administered daily over 12 mo, and the compliance of the women with these 2 treatments was assessed. From the reported serum 25(OH)D concentrations, we were able to estimate that 25-hydroxyvitamin D 3 is ;1.4-fold more potent than vitamin D 3 , but compliance with the daily supplementation regimen was poor because of intolerance to the calcium supplement. BargerLux et al (31) performed an open-label trial in which healthy young adult men (with a mean age of 28 y and a relatively good Different superscript letters represent significant differences in group means, P , 0.05 (Bonferroni-adjusted t test). ANOVA was used in the cases of dietary calcium and vitamin D, and the chi-square test was used in the case of sex.
3 Median (IQR) of nonnormally distributed variable (all such values). 4 Mean 6 SD (all such values). 5 Repeated-measures ANOVA was used to test the treatment · time interaction [P , 0.0001 and P , 0.001 for serum 25(OH)D and serum PTH, respectively]. For serum calcium, there was no significant treatment · time interaction (P . 0.9) or treatment effect (P . 0.8) but a significant (P , 0.0001) time effect, with mean values for week 5 that were significantly higher than for weeks 0 and 10.
6 All baseline blood samples were taken between 17 and 28 January 2011 and all endpoint blood samples were taken between 21 March and 8 April 2011. 7 Significant differences within each intervention group with time were investigated by ANOVA for repeat measures. d,e,f Different superscript letters represent significant differences in group means, P , 0.05 (Bonferroni-adjusted t test). The US 2010 Dietary Guidelines for Americans identified the following 4 nutrients of public concern: vitamin D, dietary fiber, calcium, and potassium (34) . Recent data on the source of usual nutrient intakes in the United States show that, in individuals .2 y of age, the median intake of vitamin D from naturally occurring food sources is only 1.7 lg/d (35) . However, the US food-composition database does not currently include 25-hydroxyvitamin D 3 data, and thus, vitamin D intakes from meat, fish, and poultry may be underestimated. Data on 25-hydroxyvitamin D 3 will be included in future releases of the US Nutrient Database for Standard Reference (36) , and thus, the use of a conversion factor for 25-hydroxyvitamin D 3 in such foods is important in the derivation of the total vitamin D activity. Fulgoni et al (35) have also highlighted the importance of vitamin D fortification or supplementation to usual intakes in the US population. The percentage of the population who did not reach the Estimated Average Requirement fell from 100% to 93.3% and 69.5% when vitamin D from naturally occurring food sources, plus enriched/fortified foods, and plus dietary supplements were accounted for, respectively. Flynn et al (3) has shown that fortified foods, and even nutritional supplements in many cases, do not significantly contribute to high intakes for vitamin D in several European countries. Bischoff-Ferrari et al (23) reported that women supplemented with the metabolite had a 2.8-fold increased odds of maintained or improved lower extremity function, a 5.7-mm Hg decrease in systolic blood pressure, and a more pronounced decrease in several markers of innate immunity, although the trial was small and intended to provide pilot data. Additional research is needed to investigate the potential of 25-hydroxyvitamin D 3 as a vitamin D supplement or a potential fortificant for health purposes in the healthy general public.
Despite significant increases in serum 25(OH)D concentrations in older adults in the current study and in the study of Bischoff-Ferrari et al (23) on supplementation with vitamin D 3 or 25-hydroxyvitamin D 3 , there was no case of hypercalcemia. Most notable was the lack of an alteration in serum calcium concentrations in the group who received 20 lg 25-hydroxyvitamin D 3 /d, in whom a mean serum 25(OH)D concentration of 134.6 nmol/L was achieved (and 92% of subjects had serum 25(OH)D concentrations .100 nmol/L at the endpoint of the study).
In conclusion, each microgram of orally consumed 25-hydroxyvitamin D 3 was 4.2 to 5 times more effective in raising serum 25(OH)D in older adults in winter than was an equivalent amount of vitamin D 3 . Additonal research is needed to verify that the bioavailability of 25-hydroxyvitamin D 3 from meat and other foods is comparable to that from supplements. However, while we await such data, a conversion factor of 5 could be used in conjunction with expected new food-composition data in relation to 25-hydroxyvitamin D 3 to better account for the total vitamin D activity of certain food groups.
